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Summary
Objectives: To study responsiveness and establish the minimal clinically important differences (MCIDs) and minimal detectable change (MDC)
in patients undergoing total knee replacement (TKR) using the Short Form 36 (SF-36) and Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC).
Methods: Prospective observational study in three public hospitals of all consecutive patients on waiting lists to undergo TKR intervention with
diagnosis of knee osteoarthritis (OA). Patients were asked to complete before the intervention and at 6 months and 2 years afterward the
SF-36 and the WOMAC health-related quality of life questionnaires (HRQoL), and additional transition questions which measured the changes
in their joint at 6 months. In both questionnaires the possible range of values is from 0 to 100 points.
Results: In WOMAC improvement at 6 months after a TKR was between 27 (stiffness) and 31 points (pain). The SF-36 showed improvements
between the 28.3 points of role physical and 2.79 of general health. From 6 months to 2 years, WOMAC improvements were between 2 and 6
points. The MCID ranged from 14.52 (stiffness) to 22.87 (pain) on the WOMAC and in the physical domains of SF-36 from 11.56 (physical
function) to 16.86 (bodily pain). On the WOMAC, the MDC ranged from 13.11 (function) to 29.12 (stiffness), and on SF-36 from 19.50 (physical
function) to 41.23 (social functioning).
Conclusions: The MCID for TKR is around 15 on WOMAC, while with the SF-36 of at least 10 points. These values should not be considered
as absolute thresholds.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Knee replacement, Responsiveness, Minimal clinically important difference, Outcomes assessment, Quality of life, Question-
naires, SF-36, WOMAC.
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Total knee replacement (TKR) is a procedure that is used
mainly on patients with a diagnosis of osteoarthritis (OA)1.
It is considered to be an effective intervention that improves
patients’ quality of life, reduces pain and increases their
functional capability2,3.
Health status measurement in OA has undergone pro-
gressive evolution in the last 60 years, with more rapid
changes in the last 25 years4. Many studies centered on
the outcomes experienced by patients with OA would
have been not considered appropriate if the adequate
health-related quality of life (HRQoL) tools are not routinely
employed. An outcome measure is essentially an assess-
ment of change which judges how the patients are now,
as compared with a previous occasion, such as before sur-
gery5. The literature supports the fact that we must use one
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measure different but complementary aspects of patients
outcomes. The speciﬁc one is more sensitive to knee prob-
lems. The generic one points out that these subjects con-
tinue to have some kind of disabilities in other aspects of
their quality of life. Among them the Medical Outcomes
Short Form 36 (SF-36) Health Survey and the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) are the most used combination in the literature8
in the evaluation of OA of lower limbs. The SF-369 and the
WOMAC10 have been used in several longitudinal studies
on patients undergoing TKR and in most cases, follow-up
has been established at 6 months, or 1 year, 2 years or
even longer8.
The ability of a measure such as an HRQoL instrument to
accurately detect change when it has occurred is called re-
sponsiveness11. The responsiveness of the SF-36 and the
WOMAC has previously been studied in several
studies12e14.
The minimal clinically important difference (MCID) and
the minimal detectable change (MDC) are related concepts
but more clinically oriented and focusing at the individual
patient level. These concepts are important given that73
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signiﬁcant at the individual level. Average effects across
a group may not be meaningful to the individual patient15,16.
This is currently an important area of research in the
HRQoL measurement ﬁeld. Even in the rheumatologic ﬁeld,
theMCID and responsiveness of the SF-36 and theWOMAC
have been already studied, but most studies have concen-
trated on pharmacological interventions17 on these patholo-
gies, due to the interest for clinical trials, or after rehabilitation
programs18,19, and not all responsiveness parameters were
reported. To the best of our knowledge, the MCID and MDC
of both instruments have not been studied simultaneously
after a TKR.
With the aim of providing with more information which
leads to established responsiveness and MCID we con-
ducted a prospective observational study with two HRQoL
tools, the SF-36 and the WOMAC, on a large sample of pa-
tients undergoing TKR.
Patients and methods
This prospective observational study took place in three
public teaching hospitals belonging to the Basque Health
Service-Osakidetza, a local government agency in the Bas-
que Country, which is part of the Spanish National Health
Service. Physicians in eachhospital were blinded to the study
goals. Our hospital ethics review board approved the study.
We developed data-collection questionnaires to retrieve
data from the medical records that included variables before
the intervention, admission, and discharge, including the in-
tervention, and complications at 6 months after discharge.
Variables collected included sociodemographic data, and
comorbidities (all those included on the Charlson Comorbid-
ity Index20).
Consecutive patients undergoing primary TKR by knee
OA between March 1999 and March 2000 and who were
managed in any of the three hospitals were eligible for the
study. Patients with malignant, severe organic or psychiatric
diseases were excluded.
All patients had to answer a question about its improve-
ment in their knee at 6 months and 2 years after the inter-
vention. This question was used as an anchor to establish
the MCID for patients undergoing a TKR intervention. The
possible responses were ‘‘a great deal better’’, ‘‘somewhat
better’’, ‘‘equal’’, ‘‘somewhat worse’’ and ‘‘a great deal
worse’’16. We used the answer ‘‘somewhat better’’ to estab-
lish the MCID for improvement.
All patients on the waiting list for TKR received a letter in-
forming them about the study and asking for their voluntary
participation. They received by mail the SF-36 and WOMAC
questionnaires, as well as additional questions on the clini-
cal aspects of their disease and on sociodemographic infor-
mation. A reminder letter was sent to those patients who
had not replied after 15 days; we sent the questionnaire
again and contacted by phone with those who had still not
replied after a further 15 days. Six months and 2 years after
the intervention, patients were sent the same ques-
tionnaires and a transitional question (anchor question).
Follow-up of those not responding was as described
previously.
The SF-36 is a generic HRQoL instrument for measuring
the quality of life9. Its 36 items cover eight domains (physi-
cal functioning, role physical, bodily pain, general health, vi-
tality, social functioning, role emotional and mental health)
and the physical and mental summary scales. The scores
for the SF-36 scales range from 0 to 100, with a higherscore indicating better health status. The SF-36 has been
translated into Spanish and validated in Spanish popula-
tions and the measurement properties were published else-
where22. We have also estimated utilities based on the
SF-36, what is called the SF-6D. The HRQoL measures
have not been designed for use in economic evaluation.
The main shortcoming is that they do not explicitly incorpo-
rate values or preferences that respondents attach to their
overall health status into their scoring algorithms23.
The WOMAC is a disease-speciﬁc, self-administered
questionnaire developed to study patients with hip or knee
OA and requires about 5 min to complete10. It has a multi-
dimensional scale made up of 24 items grouped into three
dimensions: pain (ﬁve items), stiffness (two items), and
physical function (17 items). We used the 3.1 Likert version
with ﬁve response levels for each item, representing differ-
ent degrees of intensity (none, mild, moderate, severe, or
extreme) that were scored from 0 to 4. The ﬁnal score for
the WOMAC was determined by adding the aggregate
scores for pain, stiffness, and function. The data were stan-
dardized to a range of values from 0 to 100, where 0 repre-
sents the best health status and 100 the worst possible
status. Therefore, an improvement was achieved by reduc-
ing the overall score. The original questionnaire is reliable,
valid, and sensitive to the changes in the health status of
patients with hip or knee OA13. The WOMAC has been
translated and validated in Spanish24,25.
Statistical analysis
The unit of study was the patient. In cases where two in-
terventions were done we select the ﬁrst one.
Descriptive statistics included frequency tables, means
and standard deviations (SDs). Among proportions Chi-
Square and Fisher’s exact tests were used to test for statis-
tical signiﬁcance. The t test or non-parametric Wilcoxon test
was performed for continuous variables. For the compari-
son from preintervention to 6 months after the intervention
and to 2 years after the intervention we used a paired
t test. To study the effect of comorbidities on the HRQoL
improvement and to compare the improvement at 6 months
and 2 years among the categories of the transitional ques-
tion, we performed Analysis of variance, with Scheffe’s test
for multiple comparisons, and the non-parametric Kruska-
leWallis test, since some variables present a non-normal
distribution. The dependent variable was the HRQoL im-
provement in each domain of the two questionnaires. The
independent variable was the Charlson Comorbidity Index
categorized as 0, 1 and 2 and the score before the inter-
vention in that domain.
SF-36 normalized values can be estimated so it can pro-
vide a reference value from the general population. To esti-
mate the SF-36 normalized values for each domain, ﬁrst
was standardized using the mean and SDs obtained from
a Spanish population older than 55 years and then trans-
formed to norm-based (mean¼ 50, SD¼ 10) scoring, as
suggested by the authors21. We compared the SF-36 nor-
malized values at preintervention, at 6 months and 2 years.
Floor effect, poorest score or worse HRQoL, and ceiling
effect, the best score or better HRQoL of the SF-36 and
WOMAC were estimated preintervention and at 6 months
and 2 years after the intervention. A ﬂoor effect occurs
when a high proportion of the total respondents grade them-
selves at the worse score (0 points on SF-36; 100 points on
WOMAC). A ceiling effect, inversely, occurs when a high
proportion of the total respondents grade themselves at
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WOMAC).
We calculated the Cronbach alpha statistics26 to mea-
sure the internal reliability of both HRQoL questionnaires.
To measure responsiveness at 6 months and 2 years we
employed the following indexes: effect size (ES) deﬁned as
the mean change score divided by the SD of baseline
scores; the standardized response mean (SRM) deﬁned
as the mean change score divided by the SD of changed
scores; and the Guyatt responsiveness index (GRI) which
is the ratio of average change scores of improved patients
divided by the SD of the change scores in stable patients.
Improved patients were deﬁned as those reporting at least
‘‘somewhat better’’ on the transitional question, and stable
patients were deﬁned as those reporting no change on
the transitional question13.
The MCID has been deﬁned27 as the smallest difference
between the scores in a questionnaire that the patient per-
ceives to be beneﬁcial. The MCID was estimated by the
mean change score for those patients who, at 6 months
or 2 years declared changes ‘‘somewhat better’’28 in the
transitional question about their knee improvement taking
the difference between baseline scores and the scores at
6 months or 2 years. We estimated the MCID proportion
(MCID%) which is the proportion of the sample with
a change in scores exceeding the MCID. We combined
the ‘‘somewhat worse’’ and ‘‘a great deal worse’’ categories
because the sample size of both was very small.
We estimated the standard error of measurement
(SEM), which represents the amount of error associated
with an individual subject assessment by the formula
SEM¼SD[(1R)1/2] where SD is the baseline SD and R
is the Cronbach alpha reliability coefﬁcient for a previous
analysis. With the SEM, we calculated the MDC15. The
MDC expresses the minimal magnitude of change in scores
above or belowwhich the observed change is likely to be real
at some level of conﬁdence and not just measurement error.
Its calculation is the result of the multiplication of the
SEM z-value xO2. A 95% conﬁdence level (MDC95) was
established, corresponding to a z-value of 1.96. The inter-
pretation of MDC95 is that if a patient has a change score
equal to or above the MDC95 threshold it is possible to state
with 95% conﬁdence that this change score is reliable and
not due to a measurement error. Therefore a change
greater than the MDC95 is interpreted as a true change.
We estimated the MDC proportion (MDC%) which is the
proportion of the sample with change in scores exceeding
the MDC95 at 6 months and 2 years.
All statistical analyses were performed using SAS for
Windows statistical software version 8.0 (SAS Institute,
Inc., Cary, NC) and P< 0.05 was considered signiﬁcant.
Results
During the recruitment period, 823 patients were entered
onwaiting lists to undergo TKR. Of these, 169were excluded
(23 no OA, 49 severe disease other than OA, and 97 no TKR
intervention). Of the 654 patients who fulﬁlled the selection
criteria, 545 accepted to participate and completed the ques-
tionnaires sent to them before the intervention. Of these, 526
had their medical records accessible and presented with OA.
We included 516 patients who had undergone a TKR ﬁrst
time, of which 423 completed the questionnaires both before
and 6 months after the intervention and 364 also completed
the questionnaires 2 years after the intervention. These are
the samples included in this study (Fig. 1).Patients had a mean age of 71.6 years (SD 6.7). Women
represented the 75.0% of the sample. A 54.3% of the sam-
ple had no comorbidities, a 34.7% had a Charlson Comor-
bidity Index of 1 and 11.0% had 2 or higher. There were no
statistically signiﬁcant differences among responders and
non-responders at 6 months or 2 years regarding sociode-
mographic variables and main clinical characteristics, in-
cluding comorbidities, pain or functional limitation.
At 6 months after the surgical management (Table I) the
mean improvements were higher than 27 points for all
WOMAC domains. The SF-36 captures important improve-
ments in all domains except general health and mental
health. The higher improvements were seen on the main
physical domains, role physical, physical function, and
bodily pain, all above 18 points. The mental domains (social
functioning, vitality and role emotional) had also statistically
signiﬁcant improvements although there were smaller than
18 points. From 6 months to 2 years after the intervention,
there were still minor improvements compared with 6
months after the intervention, although statistically signiﬁ-
cant in the WOMAC domains. In SF-36 domains the values
were quite similar, and there were an improvement statisti-
cally signiﬁcant only in the role physical domain (P¼ 0.04).
The general health domain had a statistically signiﬁcant
worsening (P< 0.001).
Figure 2 shows the evolution of the SF-36 normalized
scores from before the intervention to 6 months ant 2 years
after the intervention. The reference score is 50 points for
population older than 45 years. In spite of all domains ex-
perimented important improvements, only general health
domain reached 50 points although this ﬁgure was similar
823 On Waiting list
654 Fulfil selection criteria 
545 (83.3%) Accepted to participate
526 (96.5%) Medical Record accessible
516 (98.1%) Patients with first intervention
423 (82.0%) Responder at 6 months after
discharge
364 (70.5%) Responder at  2 years after
discharge
169 Excluded
23 No osteoarthritis
49 Severe disease other than OA
97 No Intervention
These are
the samples
included in
this study
Fig. 1. Patients recruitment and losses. Patients could be excluded
if their main diagnosis was not knee OA; if they had malignant, se-
vere organic or psychiatric diseases; or if they did not undergo the
surgical intervention, for any reason (death, intervention on other
hospital, refuse to have the intervention, etc.), 1 year after the inclu-
sion in the study. Each percentage (in parentheses) is estimated
based on the previous frequency except for response rate at 2
years which is based on the 516 patients who entered the study.
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Gains after TKR in HRQoL at 6 months and 2 years
Pre-intervention
x (SD)
(N¼ 516)
At 6 months
x (SD)
(N¼ 423)
P-value From 6 months to
2 years x (SD)
(N¼ 364)
P-value
WOMAC
Pain 55.56 (18.53) 31.62 (21.66) <0.001 2.89 (15.90) 0.0007
Functional limitation 61.87 (17.75) 28.25 (21.58) <0.001 2.15 (16.83) 0.016
Stiffness 58.24 (24.10) 27.22 (30.34) <0.001 5.86 (22.44) <0.001
SF-36
Physical functioning 23.28 (21.21) 23.41 (28.21) <0.001 0.24 (22.24) 0.84
Role physical 14.00 (29.34) 28.34 (45.98) <0.001 5.28 (47.40) 0.04
Bodily pain 34.65 (28.51) 18.77 (33.67) <0.001 0.82 (31.34) 0.63
General health 57.84 (20.61) 2.79 (18.61) 0.0027 4.61 (17.84) <0.001
Social functioning 56.00 (31.71) 16.88 (33.67) <0.001 2.47 (29.96) 0.12
Role emotional 63.54 (46.02) 9.76 (50.11) 0.0003 1.94 (47.50) 0.46
Vitality 43.31 (25.37) 11.65 (25.11) <0.001 2.04 (20.73) 0.075
Mental health 59.32 (24.20) 7.66 (23.45) <0.001 2.34 (21.44) 0.051
Utility SF-6D 0.55 (0.13) 0.11 (0.15) <0.001 0.005 (0.14) 0.51before the intervention. The others domains were quite near
to the 50 points reference value.
Concerning ﬂoor and ceiling effects, the WOMAC ques-
tionnaire had minor ﬂoor or ceiling effect (less than 15%
of patients in the worse or best possible score of each
domain) before the intervention. The ceiling effect was
increasing until 2 years while the ﬂoor was constant across
the time. The SF-36 domains presented ﬂoor and ceiling
effects before the intervention, while afterward the ceiling
effect dominated. Role physical, role emotional, social
function and bodily pain were the domains in which there
were more problems. Both questionnaires had a Cronbach
alpha higher than 0.75 in all domains (Table II).
Regarding WOMAC questionnaire, the different respon-
siveness parameters (Table III) evaluated at 6 months
and 2 years after TKR intervention were all above 0.90
but the GRI for stiffness. In the case of the SF-36 evaluated
at 6 months some domains, as general health, role
emotional, vitality and mental health were below 0.50. At
2 years these values were quite similar with the exception
of social function with values below 0.5. In all domains theGRI provided different results to the other parameters and
had the lower values.
All patients answered a transitional question about their
knee improvement after the intervention.
This question was used as an anchor to establish the
MCID (Table IV). At 6 months the MCID for the WOMAC
was above 14 in all domains. With the SF-36, the MCID
was quite different for each domain and ranged from 0.85
for general health to 16.86 for bodily pain domain. In
WOMAC questionnaire the MCID% was higher than 59%
for all domains while in the SF-36 was higher than 50%, ex-
cept for the role emotional domain.
The improvement between those who answer to the cat-
egory ‘‘a great deal better’’ was more homogeneous. For
the WOMAC the MCID was above 34. With the SF-36,
the physical function, role physical, bodily pain and social
function domains experimented the higher improvements,
all above 22 points.
We also estimated the MDC from the SEM and then cal-
culated the MDC%. In the WOMAC, the MDC% was higher
than 65% in pain and function domains. In the physical0,00
10,00
20,00
30,00
40,00
50,00
60,00
PF RP BP GH SF RE VT MH
PRE POST 6 meses 2 años
Fig. 2. Changes in normalized SF-36 values. Domains: PF: physical function; RP: role physical; BP: bodily pain; GH: general health; SF: social
functioning; RE: role emotional; VT: vitality; MH: mental health. Fifty is the reference score of general population older than 55 years.
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HRQoL questionnaires psychometric properties before and after TKR at 6 months and 2 years
Pre-intervention (N¼ 516) At 6 months (N¼ 423) At 2 years (N¼ 364) Cronbach alpha
% Floor % Ceiling % Floor % Ceiling % Floor % Ceiling
WOMAC
Pain 1.17 0.00 0.00 11.54 0.00 18.59 0.81
Functional limitation 0.00 0.00 0.00 2.39 0.00 3.90 0.93
Stiffness 8.75 1.95 1.44 15.79 1.12 26.61 0.81
SF-36
Physical functioning 12.55 0.59 2.43 0.24 3.10 1.41 0.89
Role physical 75.94 7.51 42.78 30.67 39.37 35.92 0.89
Bodily pain 14.93 7.66 4.24 19.95 7.04 20.00 0.77
General health 0.59 1.18 0.00 2.72 0.57 3.16 0.77
Social functioning 6.26 18.98 3.39 40.92 2.53 38.20 0.78
Role emotional 31.70 59.15 21.35 69.79 22.99 65.52 0.95
Vitality 4.78 1.25 1.03 5.67 1.43 5.14 0.82
Mental health 1.25 5.82 0.78 12.27 0.87 9.25 0.87
Utility SF-6D 0.00 0.00 0.00 0.29 0.00 2.24 0.81
Floor (worse HRQoL) and ceiling (better HRQoL).domains (physical function, physical role and bodily pain)
the SF-36 was higher than 30%. At 2 years these parame-
ters were higher in all mentioned domains (Table V).
Discussion
The results of this prospective study of a large sample of
knee OA patients who underwent TKR intervention provided
additional information of the responsiveness of two well-
known HRQoL instruments. The study provides information
about the MCID and MDC in patients undergoing TKR. This
is a way to have a clinical meaning for the scores provided
by such HRQoL tools. It also provides information on the
follow-up of such patients up to 2 years after the intervention.
We have found that the main change occur in the ﬁrst 6
months after TKR intervention. The mean improvements
measured by the WOMAC and the physical domains (phys-
ical function, role physical and bodily pain) of the SF-36
were very high. Even the mental domains showed improve-
ments above 10 points. In most cases, although impressive
these improvements are less important than that in total hip
replacement29. The only exception is the general health do-
main which shows the poorest gains.From6months to 2 years after the intervention inWOMAC,
improvements are minor, ranging from 2 to near 6 points, al-
though statistically signiﬁcant. In the SF-36 questionnaire
there are even losses on all but role physical domains.
Maybe, those losses are reﬂecting other comorbidities which
may have appeared in the time from the intervention.
As the literature30 pointed out 15% is a critical value for
ﬂoor or ceiling effect. Keeping this in mind, the WOMAC
did not present an important ﬂoor or ceiling effect before
the intervention, neither at 6 months but at 2 years the ceil-
ing effect was present. Those domains with less items, stiff-
ness and, then pain were those which presented the higher
percentages.
The SF-36, on the other hand, presented a ﬂoor effect
before the intervention in role physical and role emotional
domains, and a ceiling effect in social functioning and role
emotional domains. After surgical management the ﬂoor ef-
fect decreased at 6 months and at 2 years. The physical
function domain seems to have low ﬂoor and ceiling effects
in all cases. So, in this case it is probably showing us all the
relevant physical changes from before the intervention up to
2 years. The baseline data of both questionnaires are very
similar to other published studies31,32 as well as the data at
6 months.Table III
Responsiveness parameters after a TKR at 6 months and 2 years
At 6 months At 2 years
ES SRM GRI ES SRM GRI
WOMAC
Pain 1.71 1.46 1.20 1.86 1.55 1.74
Functional limitation 1.58 1.31 1.16 1.69 1.32 1.31
Stiffness 1.13 0.90 0.56 1.32 1.03 0.62
SF-36
Physical functioning 1.10 0.83 0.38 1.09 0.81 0.66
Role physical 0.97 0.62 0.28 1.15 0.69 0.28
Bodily pain 0.66 0.56 0.65 0.61 0.50 0.21
General health 0.14 0.15 0.04 0.07 0.07 0.31
Social functioning 0.53 0.50 0.43 0.48 0.44 0.15
Role emotional 0.21 0.19 0.17 0.18 0.16 0.04
Vitality 0.46 0.46 0.21 0.39 0.39 0.12
Mental health 0.32 0.33 0.02 0.25 0.26 0.16
Utility SF-6D 0.79 0.69 0.33 0.79 0.69 0.28
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.Results of the responsiveness parameters with the WO-
MAC are impressive since the parameters which measured
the magnitude of the change are in general above the min-
imum required (0.80) to be considered as large change33.
The SF-36 also shows good results in the physical do-
mains, as the physical function, role physical or bodily
pain, which are the relevant domains that showed improve-
ment after these interventions. These results conﬁrm previ-
ous data on TKR31,34. It is important to notice though, that
good responsiveness data are always below the total hip re-
placement29,31,34. As can be seen in Table III, the GRI pa-
rameter is always under the values of the ES and SRM.
This fact has been reported previously35 and can be asso-
ciated with the fact that in GRI only those patients who an-
swer ‘‘somewhat better’’ are included in the nominator while
for the ES and SRM all patients are included. In this way the
numerator always is greater for ES and SRM. The denom-
inator though different in their construction was quite similar
in all cases. A very recent paper has explained that these
two indices, ES and SRM are conceptually similar36.
Statistically signiﬁcant change at the group level may not
be signiﬁcant at the individual level15. From a patient stand-
point an important issue is to establish the MCID for the
intervention when using these two HRQoL tools. There is
a study17 that reported the MCID after a pharmacological in-
tervention for the WOMAC visual scale (range 0e100 mm)
and suggested a minimum of 10 mm. Other study18 was
carried out with patients undergoing a comprehensive inpa-
tient rehabilitation intervention with hip and knee OA. In this
case, MCID was about 0.8e1.01 points (range 0e10 point
scale). In another study19 the values for the WOMAC do-
mains were around 0.7 for improvement and for the SF-36
questionnaire, 7.8 in the bodily pain domain and 3.3 in the
physical function domain. Regarding WOMAC, although
the improvements are in different scales these MCIDs are
very similar.
The MCID at 6 months, based on our results, is between
14 and 22 points (range 0e100 points scale) for theWOMAC
domains. In the case of the SF-36, there is more variety, from
the 3 to 11 points for most mental domains, and from 11 to 16
for physical domains. Those improvement scores were,
usually, higher in the hip replacement patients29.
The higher MCID observed in our study compared with
the previously published17,18 could be attributable to the
lower severity of the disease of those patients compared
with the patients who have undergone TKR.
Importantly, when we asked our patients about the
changes in their knee most of them (69.8%) reported ‘‘a
great deal better’’ beneﬁt. The group of those who answer
that they were ‘‘somewhat better’’ was small (18.1%) which
in part limited our conclusions and the estimation of MCID.
In the case of worsening, we have to put together those who
answer ‘‘somewhat worse’’ or ‘‘a great deal worse’’ since
the sample size was very small, not allowing us to have
two separated categories.
A possible limitation was the anchor question (transitional
question). We employed a Likert scale with ﬁve options,
from ‘‘a great deal better’’ to ‘‘a great deal worse’’. Some
other authors37 have used a 15 options answer scale, or
a seven point Likert scale27. Taking into account the high
mean age of our samples and their low level of education,
in our case, this option would have made the answering
of the questionnaire far more complicated. An additional
criticism to our method is that we just employed one transi-
tional question, not one for each domain, as it has been
suggested38. Again, this would have increased the length
of the questionnaire and increased the rate of missing
279Osteoarthritis and Cartilage Vol. 15, No. 3Table V
MCID, MDC% and MCID% for TKR at 2 years for the WOMAC and SF-36
A great deal
better (N¼ 238)
Somewhat better
(N¼ 65)
Equal
(N¼ 22)
Worse
(N¼ 24)
P-value MDC% MCID%
WOMAC
Pain 39.51 (20.22) 27.98 (19.44) 13.57 (16.06) 18.39 (26.04) <0.001 249 (70.34) 226 (63.84)
Functional limitation 36.95 (20.66) 20.84 (18.20) 8.58 (15.89) 8.85 (24.00) <0.001 280 (78.43) 230 (64.43)
Stiffness 38.35 (28.19) 21.35 (27.22) 11.90 (34.57) 10.94 (36.73) <0.001 183 (51.40) 237 (66.57)
SF-36
Physical functioning 28.87 (28.217) 11.07 (21.65) 8.04 (16.84) 11.25 (28.07) <0.001 207 (58.64) 228 (64.59)
Role physical 46.04 (47.21) 13.16 (39.56) 8.75 (47.49) 12.70 (43.43) <0.001 130 (41.94) 159 (51.29)
Bodily pain 22.49 (34.99) 6.69 (29.20) 5.32 (31.38) 0.83 (31.13) <0.001 94 (26.78) 224 (63.82)
General health 1.91 (18.49) 7.30 (16.60) 13.25 (23.53) 11.13 (19.79) <0.001 24 (6.94) 226 (65.32)
Social functioning 20.73 (32.89) 6.15 (32.37) 5.63 (42.24) 0.52 (30.72) 0.0002 75 (21.25) 197 (55.81)
Role emotional 13.30 (50.23) 2.42 (47.94) 5.26 (60.11) 7.58 (65.00) 0.3849 77 (25.08) 77(25.08)
Vitality 15.23 (24.19) 3.44 (23.21) 8.33 (29.59) 5.58 (22.08) <0.001 69 (21.10) 200 (61.16)
Mental health 8.96 (21.19) 4.02 (23.45) 7.29 (25.81) 3.65 (25.35) 0.0516 59 (18.21) 148 (45.68)
Utility SF-6D 0.14 (0.15) 0.05 (0.14) 0.03 (0.18) 0.004 (0.16) <0.001 85 (31.95) 174 (65.41)
Means and, in parenthesis, standard deviations. The category of worse included two answer categories: ‘‘Somewhat worse’’ and ‘‘A great
deal worse’’. Somewhat better¼MCID.patients or items. But, when considering our results as
MCID reference for the TKR intervention these limitations
must be kept in mind.
Other problem as in every prospective design is the per-
centage of non-respondents or missing values. In our case,
we have a very good response rate before the intervention,
higher than 80%, and at 6 months and 2 years (higher than
70%). But, in the whole, we lost 44.3% from those who fulﬁll
the selection criteria to 2 years after discharge. This is
a usual ﬁnding when doing so large follow-up studies. In
all subsequent follow-ups, at 6 months and 2 years, we
sent up to two reminders and contact by phone with non-re-
spondents. When comparing those who responded with
those who did not, we found no differences in the most rel-
evant variables. Therefore, although a bias can be present
in our study due to those losses, we think it likely is minor
and that our results can be generalized to the whole
sample.
In conclusion, the results of this prospective observa-
tional study provide more information about the MCID and
MDC that should be expected on patients undergoing
a TKR. This way, clinicians may interpret the results ob-
tained with these HRQoL tools, which may help to their
use not only in research but also in clinical practice.
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